S&P Futures

7,640.25

+26.25

+0.34%

Dow Futures

52,119.00

+201.00

+0.39%

Nasdaq Futures

28,717.25

+183.25

+0.64%

Russell 2000 Futures

2,835.60

+14.30

+0.51%

10-Yr Bond

4.9290

-0.0600

-1.20%

VIX

19.46

+0.04

+0.21%

Gold

3,909.80

+10.90

+0.28%

Bitcoin USD

77,537.50

-355.59

-0.46%

Crude Oil Dec 26

99.55

-4.57

-4.39%

US Private Equity

10,850.63

-82.20

-0.75%

Tokyo - Delayed Quote JPY

Mochida Pharmaceutical Co., Ltd. (4534.T)

3,265.00 -20.00 (-0.61%)

At close: 3:30:00 PM GMT+9

Loading Chart for 4534.T

Chart Range Bar

Interval:

In partnership with ChartIQ

Assessment of the Pulmonary Arterial Hypertension (PAH) Market 2026-2036 Featuring United Therapeutics, Mochida Pharmaceutical, Johnson & Johnson, Merck, and Gossamer Bio

Initiation of a Phase III Clinical Study of BON-001 for Nausea and Vomiting of Pregnancy in Japan

Mobilize your Website

View Site in Mobile | Classic

Share by:

U.S. markets open in 1h 12m

Mochida Pharmaceutical Co., Ltd. (4534.T)

Recent News

Assessment of the Pulmonary Arterial Hypertension (PAH) Market 2026-2036 Featuring United Therapeutics, Mochida Pharmaceutical, Johnson & Johnson, Merck, and Gossamer Bio

Initiation of a Phase III Clinical Study of BON-001 for Nausea and Vomiting of Pregnancy in Japan

Initiation of a Phase III Clinical Study of BON-001 for Nausea and Vomiting of Pregnancy in Japan

Related Tickers